Substantia nigra nigrosome-1 imaging correlates with the severity of motor symptoms in Parkinson's disease

[1]  C. Sohn,et al.  Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes. , 2021, Radiology.

[2]  Christian Desrosiers,et al.  Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature , 2021, Frontiers in Aging Neuroscience.

[3]  E. Kim,et al.  Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease. , 2021, Parkinsonism & related disorders.

[4]  S. Lehéricy,et al.  Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease. , 2020, Brain : a journal of neurology.

[5]  Yan Li,et al.  Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease , 2019, NeuroImage: Clinical.

[6]  Quoc V. Le,et al.  Randaugment: Practical automated data augmentation with a reduced search space , 2019, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW).

[7]  Guangzong Li,et al.  The diagnostic value of SNpc using NM-MRI in Parkinson’s disease: meta-analysis , 2019, Neurological Sciences.

[8]  J. Gillard,et al.  Introduction to quantitative susceptibility mapping and susceptibility weighted imaging. , 2019, The British journal of radiology.

[9]  Jorge Munilla,et al.  Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks , 2019, Front. Neuroinform..

[10]  R. Zivadinov,et al.  Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[11]  Eung Yeop Kim,et al.  Nigrosome 1 imaging: technical considerations and clinical applications. , 2019, The British journal of radiology.

[12]  Quoc V. Le,et al.  EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks , 2019, ICML.

[13]  Jon Kleinberg,et al.  Transfusion: Understanding Transfer Learning for Medical Imaging , 2019, NeurIPS.

[14]  A. Strafella,et al.  New Imaging Markers for Movement Disorders , 2018, Current Neurology and Neuroscience Reports.

[15]  P. Pal,et al.  Three‐dimensional neuromelanin‐sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease , 2018, European journal of neurology.

[16]  Yen F. Tai,et al.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism , 2018, Movement disorders clinical practice.

[17]  P. Spano,et al.  The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging , 2017, Front. Aging Neurosci..

[18]  W. Poewe,et al.  Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[19]  E. Tolosa,et al.  Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility‐weighted imaging in idiopathic rapid eye movement sleep behavior disorder , 2016, Annals of neurology.

[20]  Ji Young Yun,et al.  Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECT , 2016, Movement disorders : official journal of the Movement Disorder Society.

[21]  Hiroki Shirato,et al.  3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease , 2013, Neuroradiology.

[22]  Z. Cho,et al.  Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease , 2012, Annals of neurology.

[23]  K. Kashihara,et al.  Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.

[24]  V. Sossi,et al.  Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease , 2011, Annals of neurology.

[25]  Andreas Zwergal,et al.  Gait disturbances in old age: classification, diagnosis, and treatment from a neurological perspective. , 2010, Deutsches Arzteblatt international.

[26]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[27]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[28]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[29]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[30]  Xin-She Yang,et al.  Convolutional Neural Networks Applied for Parkinson's Disease Identification , 2016, Machine Learning for Health Informatics.